The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study

Abstract Background Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid. The objective of our study was to prospectively estimate the association between g...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Vaia Lambadiari, Aikaterini Kountouri, Foteini Kousathana, Emmanouil Korakas, Georgios Kokkalis, Sofia Theotokoglou, Lina Palaiodimou, Pelagia Katsimbri, Ignatios Ikonomidis, Konstantinos Theodoropoulos, Evangelia Papadavid
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2021-02-01
Sarja:	BMC Endocrine Disorders
Aiheet:	Bullous pemphigoid Dipeptidyl-peptidase 4 inhibitors Vildagliptin Gliptins
Linkit:	https://doi.org/10.1186/s12902-021-00689-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!